Document is current
Any future updates will be listed below
-
Authors
Vaziri-Gohar, Ali
Cassel, Joel
Mohammed, Farheen S.
Zarei, Mehrdad
Hue, Jonathan J.
Hajihassani, Omid
Graor, Hallie J.
Srikanth, Yellamelli V. V.
Karim, Saadia A. https://orcid.org/0000-0002-3727-0667
Abbas, Ata https://orcid.org/0000-0001-8272-1853
Prendergast, Erin
Chen, Vanessa
Katayama, Erryk S. https://orcid.org/0000-0002-2206-8124
Dukleska, Katerina
Khokhar, Imran
Andren, Anthony
Zhang, Li
Wu, Chunying
Erokwu, Bernadette
Flask, Chris A.
Zarei, Mahsa
Wang, Rui
Rothermel, Luke D.
Romani, Andrea M. P.
Bowers, Jessica
Getts, Robert
Tatsuoka, Curtis
Morton, Jennifer P.
Bederman, Ilya
Brunengraber, Henri
Lyssiotis, Costas A. https://orcid.org/0000-0001-9309-6141
Salvino, Joseph M. https://orcid.org/0000-0002-2184-5980
Brody, Jonathan R.
Winter, Jordan M. https://orcid.org/0000-0002-5200-6557
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R37CA227865-01A1)
- License Information
-
More Information
Article History
Received: 19 March 2021
Accepted: 2 May 2022
First Online: 9 June 2022
Competing interests
: R.G. is an inventor on multiple issued patents and patent applications covering the manufacture and use of 3DNA technology as part of his role in Code Biotherapeutics, Inc. He is also an employee and officer of Code Biotherapeutics, Inc. and has stock and stock options. C.A.L. has received consulting fees from Astellas Pharmaceuticals and Odyssey Therapeutics and is an inventor on patents pertaining to Kras-regulated metabolic pathways, redox control pathways in cancer and targeting of the GOT1-pathway as a therapeutic approach. J.M.S. is a coauthor on patents on IDH1 inhibitors, and has received sponsored research funding from the Barer Institute and patents pending to Wistar Institute. J.M.W., along with University Hospitals, filed the following patent application on 24 September 2020: Methods for Treating Wild Type Isocitrate Dehydrogenase 1 Cancers. Information regarding this patent application is as follows: PCT/US20/52445 filed 24 September 2020, Claiming Priority to US 62/911,717 filed 7 October 2019, file nos: UHOSP-19738 | 2019-014.
